by In2Pharma | Mar 30, 2021 | News
The Netherlands As from 1 January 2021, there is a new national reporting point for healthcare professionals (i.e. doctors, pharmacists…) to report any kind of incidents with medication: from errors in the prescription up to the administration of medicines, including...
by In2Pharma | Mar 29, 2021 | News
Europe Regulation (EU) 2019/515 on the mutual recognition of goods lawfully marketed in another Member State started to apply on 19 April 2020 and replaced Regulation (EC) No 764/2008. The aim of the Regulation is to strengthen the functioning of the single market by...
by In2Pharma | Jun 10, 2020 | News
Europe An updated regulation (2019/515) on the mutual recognition of goods lawfully marketed in another Member State is applied as of 19 April 2020. The mutual recognition principle ensures market access for goods that are not, or are only partly subject to EU...
by In2Pharma | May 8, 2019 | News
EU With the Mutual Recognition Agreement between Europe and the US, inspections are to be mutually recognised in the future. The FDA’s approval of the EU Member States proceeds successively. Two more countries have recently been approved: Bulgaria and Cyprus....
